Objective: Simulation software has aided the estimation of organ dose from computed tomography (CT) examinations. The aim of this study was to use the CT-Expo (SASCRAD, Fritz-Reuter-Weg, Buchholz, Germany) software to determine volume CT dose index (CTDI vol ), dose length product (DLP), organ dose and effective dose.
INTRODUCTION
Ionizing radiation is capable of causing cell death or radiation-induced reproductive failure, which can lead to changes in the genes involved in cell growth, loss of normal nuclear structure, degradation of DNA and carcinogenesis. [1] [2] [3] Despite its ability to completely alter or change genetic structure, it is indispensable to modern medicine for diagnosis and treatment. Medical practice involving ionizing radiation includes diagnostic examinations, interventional procedures, and radiotherapy treatments typically undertaken in a radiology, nuclear medicine, or radiation oncology department or clinic. Globally, it is estimated that approximately 3.6 billion diagnostic examinations and 6 million therapeutic treatments are performed annually. [4] Primarily, the people exposed to ionizing radiation for medical purposes are the patients themselves. These exposure situations are deliberate and voluntary with some diagnostic or therapeutic health benefits to be gained. Recent figures show that diagnostic medical exposures, including radiology and nuclear medicine, account for about one-fifth of the average annual output dose to the global population from all sources. [5] The radiation effects associated with ionizing radiation can be classified as either deterministic (effect of radiation has a threshold to cause damage) or stochastic (no radi-ation threshold is necessary to cause damage). There is irrefutable evidence from epidemiological studies that ionizing radiation exposure at high doses is associated with an increase in cancer incidence and morbidity. [6] To accurately evaluate the associated radiation-induced risks, knowledge of doses to the specific region or organ is recommended in the determination of the probability of inducing any deterministic effects or corresponding stochastic risk of carcinogenesis and genetic effects. [7, 8] Among diagnostic modalities, computed tomography (CT) is the greatest contributor to population dose, although it accounts for a much smaller proportion of the total number of examinations. Optimizing patients' procedures, and maintaining good practice is a priority for all diagnostic radiological examinations, including CT examinations. The risk is greater for children, who are more radiosensitive than adults. [9] Since its launch into clinical practice as a scanning technology more than 40 years ago, CT has developed and advanced, and its use has become more widespread. However, concerns over patient radiation dose risk from CT scans have grown, and the introduction of multi-slice scanners has focused further attention on this issue. [10, 11] In 2007, the International Commission on Radiological Protection (ICRP) provided the Diagnostic Reference Levels (DRL) to be used in medical diagnosis for the management and evaluation of CT dose quantities and for identification of unusually high doses. The DRL is not a limitation of diagnostic radiation dose or a reference for organ doses, but provides quantities to compare protocols, promote optimization, and avoid unnecessary doses.
In Nigeria, large radiation doses to patients were observed in ordinary X-ray exposures, and large variations in the radiation dose were also observed both within and between hospitals. It is therefore likely that similar situations exist with CT. Records of radiation doses from CT exams in Nigeria and the harmonization of CT protocols and dose reference levels have not been established due to poor implementation of regulatory policies and monitoring, but there is evidence of a proliferation of CT facilities in the country. [11, 12] The need to add consideration of organ dose tolerance in relation to dose optimization by reviewing CT protocols has now become even more pertinent, since organ doses to patients undergoing CT examinations are generally much higher than those associated with conventional, mammography and fluoroscopy examinations.
This study was intended to determine the radiation dose delivered to adult patients during CT examination at 2 hospitals (radiology department) in North-Central Nigeria using CT-Expo software, which is a representation of a hermaphrodite mathematical model. The CT dose parameters to be determined were the volume CT dose index (CTDI vol ), dose length product (DLP), effective dose (E), and specific organ dose, and the aim was to compare the results with other relevant studies.
MATERIAL AND METHODS
A 6-month retrospective study of CT scans of adult patients at the diagnostic radiology departments of 2 tertiary hospitals in North-Central Nigeria were recorded during the period from October 2016 to March 2017. A total of 171 adult cases were selected and the details were recorded. Demographic information (age and sex) of the patients were noted to ensure that only adult patients were included in the study. The examinations under review were routine, non-contrast CT scans of the head, chest, and abdomen.
The hospitals in the study passed a quality control test. The type and specification of the device in use at each unit was Toshiba Aquillion 16-slice scanner (Toshiba, Corp., Tokyo, Japan) (Hospital A) and Philips Brilliance 16-slice (Koninklijke Philips N.V., Amsterdam, Netherlands) (Hospital B). To calculate the organ dose and E, the scan parameters of the Digital Imaging and Communications in Medicine (DICOM) headers were used: tube current, tube voltage, scan length, pitch, beam collimation, table feed, rotation time, and slice thickness for each patient selected. These parameters were recorded on a separate data sheet. In contrast to similar programs for CT dose calculations, CT-Expo offers the user a number of unique features, such as: [13] a) Dose calculations for all age groups (adults, children, The scans of body parts examined were matched to phantoms, with the start and end of scans defined as from the top of the head through to the base of the skull for a head scan, from the clavicles through the base of the lungs for a chest scan, and from the top of the liver to the top of the pubic symphysis for an abdomen scan. Exam-technique parameters were used to estimate organ doses. The results of organ dose and E using tissue weighting factors from ICRP publication no. 103 were recorded. [14] Statistical analysis
The data analysis was performed using SPSS for Windows, Version 16.0 (SSPSS Inc., Chicago, IL, USA). Descriptive statistics, the one-sample t-test, and the independent sample t-test were used at a 95% level of significance. P<0.05 was considered statistically significant.
RESULTS
The distribution of head (64%), chest (8%), and abdomen (28) examinations performed for the 171 patients who underwent CT procedures in the 2 teaching hospital radiology CT units located in North-Central Nigeria in the study is demonstrated in a pie chart in Figure 1 .
Assessment of the scan parameters of the 2 CT units revealed no statistically significant difference in mAs (milliampere seconds) (p=0.594) or scan length (p=0.368); however, differences were seen in peak kilovoltage (kVp) p=0.007) and pitch (p=0.024) in the 3 body regions ( Table 1 ).
The CTDI vol at the 75 th percentile for CT unit A for the head, chest, and abdomen were 140, 19, and 112.63 mGy, respectively. Similarly, for unit B, for the head, chest, and abdomen, the finding were 60.9, 10.6, and 15.5 mGy, respectively. An independent sample t-test indicated no significant difference in the CTDI vol at the 75 th per- [15] the USA (p=0.199), [16] Ireland (p=0.185), [17] Switzerland (p=0.210), [18] Germany (p=0.221), [19] Kenya (p=0.218), [20] and Nigeria (p=0.215) [21] was not significant. The comparison of the CTDI vol at the 75 th percentile for CT unit B with the EC group (p=0.531), the USA (p=0.940), Ireland (p=0.933), Switzerland (p=0.968), Germany (p=0.892), Kenya (p=0.848), and Nigeria (p=0.872) also yielded no statistically significant difference ( Table 2 of this study's DLP at the 75 th percentile for CT unit B with EC members (p=0.920), the USA (p=0.736), Ireland (p=0.297), Switzerland (p=0.782), Germany (p=0.967), Kenya (p=0.120), and Nigeria (p=0.243) revealed no statistically significant difference (Table 3) .
Furthermore, comparison of the organ dose to the head (brain, eye lens, red bone marrow, and skin), chest (breast, lung, thyroid, and skin), and abdomen (liver, stomach, ovaries, and skin) between the 2 CT units were not statistically different (p=0.677). There were no difference in mean dose for CT unit A and studies conducted in Nigeria (p=0.120), [22] Turkey (p=0.385), [23] Tanzania (p=0.163), [24] the UK (p=0.125), [25] and Japan (p=0.051). [26] Similarly no significant differences were seen for CT unit B and studies conducted in Turkey (p=0.414), Tanzania (p=0.447), Nigeria (p=0.610), the UK (p=0.788), and Japan (p=0.172) ( Table 4 ).
The mean E value from both scanners is presented in a graph (Fig. 2) . The mean E delivered by CT unit A to the head, chest, and abdomen was 9.5, 7.8, and 37.8 mSv, respectively, and for CT unit B, the results were 3.7, 8.5, and 11.9 mSv, respectively. There was no statistically significant result in either case (p=0.360) ( Table 5) .
DISCUSSION
The CTDI vol at the 75 th percentile for CT unit A showed the greatest difference in scans of the head, when compared with other studies. It was 80% higher than that reported for the EC, 84.3% higher than seen in the USA, 82% higher than Ireland, 73.2% higher than Switzerland and Germany, and 78% higher than that reported in Kenya and Nigeria. This difference could largely be as a result of the kVp and pitch used, as well as the type of scanner used. The difference in CTDI vol at the 75 th percentile between CT unit B for the head and other studies was below 7%.
The CTDI vol at the 75 th percentile for CT unit A for the chest was higher compared with studies conducted in the USA (23.5%), Ireland (53.3%) Switzerland (62.1%), Germany (45.2%), and Nigeria (11.1%), but was the same as that reported in Kenya. The CTDI vol at the 75 th percentile for CT unit B for the chest was lower than that seen in the EU (95.6%), the USA (34.4%), Ireland (3.7%), Germany (12.4%), Kenya (56.8%), and Nigeria (46.4%), but was higher than the results from Switzerland (5.8%), with the least difference seen in a comparison with Ireland.
The CTDI vol at the 75 th percentile for CT unit A for the abdomen was highest when contrasting with the EC (105.2%), the USA (139.7%), Ireland (161.5%), Switzerland (153%), Germany (139.7%), Kenya (139.7%), and Nigeria (139.7%). The abdomen had the highest percentage of difference in CTDI vol . The percentage of difference for CTDIvol at the 75 th percentile for CT unit B for the abdomen was lower compared to the EC, the USA, Germany, Kenya, and Nigeria, but was higher than that seen in Ireland (25.5%) and Switzerland (3.3%).
The DLP at the 75 th percentile for CT unit A for the head was quite a bit higher than that of the EC, the USA, Ireland, Switzerland, Germany, Kenya, or Nigeria. The DLP at the 75 th percentile for CT unit B for the head was lower in this study than previously reported values in Kenya and Nigeria. The percentage of difference between CT unit A and B was 80.7%. The chest DLP in CT unit A was similar in value to the results of another study conducted in Nigeria, but was higher than other studies conducting similar research. The DLP for the chest in CT unit B had the greatest difference when compared with research conducted in Kenya (64.5%). The DLP for the abdomen for CT unit A was greater than the other studies used, but the CT unit B abdomen DLP value was significantly lower compared with that of the EC group, the USA, Germany, Kenya, and Nigeria.
The CT-Expo results showed no difference in organ dose between CT units A and B. The CT-Expo software results for this study were also compared with the imPACT dosimetric calculator (ImPACT scanner evaluation group, London, UK), and the results obtained revealed no difference between our study and research conducted in Nigeria The mean difference in E to the head for both CT units was highest compared to Osei and Darko (114.3%), [27] Clarke et al. (134.2%), [28] Tsai (122%), [29] Origgi et al. (114.3%), [30] Aldrich et al. (80.9%), [31] an EC group (107%) [32] and the UK (126%). [33] The E to the chest in this study was less than that reported by Tsai et al., Aldrich et al., and the EC group. However, the mean E to the abdomen was higher than other values studied.
CONCLUSION
The CT-Expo software was a good tool for accessing patient doses in the 2 facilities studied (CT units A and B). The CTDI vol and DLP for CT unit A to the head and abdomen were higher than those of CT unit B, and were also the highest when compared with other studies, although these differences were not statistically significant when compared with other studies. CT unit B results were consistent with other studies, suggesting that the CT unit B protocol might be useful to CT unit A in achieving dose optimization. Nevertheless, it is important to remember that dose discrepancies may have been greatly affected by kVp and pitch, which were statistically significant in this study.
